Hedge Fund - Aquilo Capital Management
Regenxbio Inc. (RGNX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $1,939,809 | 3.48% | 271,302 | $7.44 |
| 2 | 2024 - Q4 (2024-12-31) | $2,676,914 | 4.03% | 346,302 | $9.39 |
| 3 | 2024 - Q3 (2024-09-30) | $9,763,127 | 7.4% | 930,708 | $12.19 |
| 4 | 2024 - Q2 (2024-06-30) | $10,603,102 | 10.22% | 906,248 | $15.56 |
| 5 | 2024 - Q1 (2024-03-31) | $19,094,645 | 14.31% | 906,248 | $17.79 |
| 6 | 2023 - Q4 (2023-12-31) | $14,403,511 | 8.97% | 802,424 | $17.61 |
| 7 | 2023 - Q3 (2023-09-30) | $13,948,599 | 12.63% | 847,424 | $18.12 |
| 8 | 2023 - Q2 (2023-06-30) | $17,393,579 | 9.63% | 870,114 | $19.27 |
| 9 | 2023 - Q1 (2023-03-31) | $15,714,475 | 6.51% | 831,014 | $22.13 |
| 10 | 2022 - Q4 (2022-12-31) | $20,359,473 | 7.64% | 897,684 | $22.61 |
| 11 | 2022 - Q3 (2022-09-30) | $25,576,000 | 9.21% | 967,684 | $29.67 |
| 12 | 2022 - Q2 (2022-06-30) | $28,842,000 | 9.84% | 1,167,684 | $24.98 |
| 13 | 2022 - Q1 (2022-03-31) | $37,129,000 | 5.45% | 1,118,684 | $27.78 |
| 14 | 2021 - Q4 (2021-12-31) | $33,145,000 | 3.75% | 1,013,596 | $34.05 |
| 15 | 2021 - Q3 (2021-09-30) | $35,177,000 | 6.38% | 839,139 | $35.98 |
| 16 | 2021 - Q2 (2021-06-30) | $23,133,000 | 6.01% | 595,444 | $35.77 |
| 17 | 2021 - Q1 (2021-03-31) | $19,083,000 | 3.44% | 559,444 | $42.65 |
| 18 | 2020 - Q4 (2020-12-31) | $22,836,000 | 4.74% | 503,444 | $34.94 |
| 19 | 2020 - Q3 (2020-09-30) | $14,056,000 | 1.48% | 510,760 | $32.60 |
| 20 | 2020 - Q2 (2020-06-30) | $20,384,000 | 4.11% | 553,453 | $37.28 |
| 21 | 2020 - Q1 (2020-03-31) | $8,847,000 | 3.44% | 273,211 | $41.66 |
| 22 | 2019 - Q4 (2019-12-31) | $11,012,000 | 4.13% | 268,778 | $39.50 |
The displayed share prices are average quarterly stock market prices.